Manulife (Manufacturers Life Insurance)
SRGA

Manulife (Manufacturers Life Insurance)’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,129
Closed -$139K – 3338
2021
Q1 		$139K Buy
2,129
+1,054
+98% +$73.5K ﹤0.01% 2999
2020
Q4 		$71K Sell
1,075
-167
-13% -$10.9K ﹤0.01% 2970
2020
Q3 		$67K Hold
1,242
– – ﹤0.01% 2871
2020
Q2 		$106K Sell
1,242
-75
-6% -$5.59K ﹤0.01% 2742
2020
Q1 		$68K Buy
1,317
+76
+6% +$7.94K ﹤0.01% 2675
2019
Q4 		$102K Sell
1,241
-63
-5% -$4.42K ﹤0.01% 2795
2019
Q3 		$113K Hold
1,304
– – ﹤0.01% 2800
2019
Q2 		$166K Sell
1,304
-5
-0.4% -$720 ﹤0.01% 2740
2019
Q1 		$236K Sell
1,309
-49
-4% -$7.09K ﹤0.01% 2346
2018
Q4 		$151K Sell
1,358
-138
-9% -$18K ﹤0.01% 2385
2018
Q3 		$202K Sell
1,496
-14
-0.9% -$1.93K ﹤0.01% 2766
2018
Q2 		$208K Sell
1,510
-7
-0.5% -$963 ﹤0.01% 3108
2018
Q1 		$209K Buy
1,517
+7
+0.5% +$953 ﹤0.01% 2991
2017
Q4 		$185K Sell
1,510
-19
-1% -$2.61K ﹤0.01% 3064
2017
Q3 		$209K Buy
1,529
+5
+0.3% +$755 ﹤0.01% 2943
2017
Q2 		$268K Sell
1,524
-91
-6% -$12.9K ﹤0.01% 2773
2017
Q1 		$194K Buy
1,615
+149
+10% +$15.5K ﹤0.01% 2857
2016
Q4 		$143K Buy
1,466
+30
+2% +$2.75K ﹤0.01% 3033
2016
Q3 		$135K Sell
1,436
-107
-7% -$10.7K ﹤0.01% 3047
2016
Q2 		$167K Buy
1,543
+178
+13% +$20.8K ﹤0.01% 2860
2016
Q1 		$165K Buy
1,365
+34
+3% +$3.57K ﹤0.01% 2736
2015
Q4 		$159 Hold
1,331
– – ﹤0.01% 2830
2015
Q3 		$227 Hold
1,331
– – ﹤0.01% 2550
2015
Q2 		$258 Buy
1,331
+9
+0.7% +$1.67K ﹤0.01% 2648
2015
Q1 		$196 Buy
1,322
+46
+4% +$7K ﹤0.01% 2753
2014
Q4 		$199 Sell
1,276
-34
-3% -$4.9K ﹤0.01% 2656
2014
Q3 		$188 Sell
1,310
-29
-2% -$4.21K ﹤0.01% 2680
2014
Q2 		$174K Sell
1,339
-223
-14% -$28.3K ﹤0.01% 2831
2014
Q1 		$192 Buy
1,562
+11
+0.7% +$1.19K ﹤0.01% 2749
2013
Q4 		$165 Sell
1,551
-30
-2% -$2.91K ﹤0.01% 2841
2013
Q3 		$178 Sell
1,581
-22
-1% -$2.5K ﹤0.01% 2737
2013
Q2 		$180K Buy
+1,603
New +$196K ﹤0.01% 2656

Other funds holding SRGA

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SRGA Position: Q2 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2021, closing a stake of 2,129 shares — an estimated $139K sold.

Manulife (Manufacturers Life Insurance) first reported a position in SRGA in Q2 2013 and held it in 32 quarters. The position peaked at $268K in Q2 2017. 89 funds tracked by Wall St. Rank hold SRGA as of Q2 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 2,129 Surgalign Holdings, Inc. Common Stock shares in Q2 2021, an estimated $139K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 32 quarters.
  • Manulife (Manufacturers Life Insurance)'s Surgalign Holdings, Inc. Common Stock position peaked at $268K in Q2 2017.
  • 89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2021, filed 12 Aug 2021.